Long-term evaluation of home-based pulmonary rehabilitation in patients with fibrotic idiopathic interstitial pneumonias

ERJ Open Research

Volumn 5, Issue 2, 2019, Pages

  Wallaert, Benoit ^a   Duthoit, Louise ^a   Drumez, Elodie ^b   Behal, Hélène ^b   Wemeau, Lidwine ^a   Chenivesse, Cécile ^a   Grosbois, Jean Marie ^c  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c rue Pietralunga   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIFIBROTIC AGENT; ANXIOLYTIC AGENT; CARBON MONOXIDE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

AGED; ARTERIAL OXYGEN SATURATION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE SEVERITY; EXERCISE TOLERANCE; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEMOGLOBIN BLOOD LEVEL; HOME REHABILITATION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERSTITIAL PNEUMONIA; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MOOD; OBSERVATIONAL STUDY; OXYGEN THERAPY; PLETHYSMOGRAPHY; PSYCHOSOCIAL CARE; PULMONARY REHABILITATION; PULSE OXIMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; SIX MINUTE WALK TEST; SPIROMETRY; TOTAL LUNG CAPACITY; VISUAL ANALOG SCALE; VISUAL SIMPLIFIED RESPIRATORY QUESTIONNAIRE;

EID: 85081946755     PISSN: None     EISSN: 23120541     Source Type: Journal    
DOI: 10.1183/23120541.00045-2019     Document Type: Article

References (40)

1. Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188: 733-748.
2. De Vries J, Kessels BL, Drent M. Quality of life of idiopathic pulmonary fibrosis patients. Eur Respir J 2001; 17:954-961.
3. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188: e13-e64.
4. Gomes-Neto M, Silva CM, Ezequiel D, et al. Impact of pulmonary rehabilitation on exercise tolerance and quality of life in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis. J Cardiopulm Rehabil Prev 2018; 38: 273-278.
5. Dowman L, Hill CJ, Holland AE. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev 2014; 10: CD006322.
6. Alison JA, McKeough ZJ, Johnston K, et al. Australian and New Zealand pulmonary rehabilitation guidelines. Respirology 2017; 22: 800-819.
7. Cheng L, Tan B, Yin Y, et al. Short- and long-term effects of pulmonary rehabilitation for idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Clin Rehabil 2018; 32: 1299-1307.
8. Dowman LM, McDonald CF, Hill CJ, et al. The evidence of benefits of exercise training in interstitial lung disease:a randomised controlled trial. Thorax 2017; 72: 610-619.
9. Ryerson CJ, Cayou C, Topp F, et al. Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study. Respir Med 2014; 108: 203-210.
10. Vainshelboim B, Oliveira J, Fox BD, et al. Long-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis. Lung 2015; 193: 345-354.
11. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis:evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
12. European Respiratory Society. Standardized Lung Function Testing. Official statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 1-100.
13. King TE, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2083-2092.
14. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement:guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
15. Grosbois JM, Gicquello A, Langlois C, et al. Long-term evaluation of home-based pulmonary rehabilitation in patients with COPD. Int J Chron Obstruct Pulmon Dis 2015; 10: 2037-2044.
16. Delourme J, Stervinou-Wemeau L, Salleron J, et al. Six-minute stepper test to assess effort intolerance in interstitial lung diseases. Sarcoidosis Vasc Diffuse Lung Dis 2012; 29: 107-112.
17. Grosbois JM, Riquier C, Chehere B, et al. Six-minute stepper test: a valid clinical exercise tolerance test for COPD patients. Int J Chron Obstruct Pulmon Dis 2016; 11: 657-663.
18. Pichon R, Couturaud F, Mialon P, et al. Responsiveness and minimally important difference of the 6-minute stepper test in patients with chronic obstructive pulmonary disease. Respiration 2016; 91: 367-373.
19. Lepine JP, Godchau M, Brun P. Anxiety and depression in inpatients. Lancet 1985; 2: 1425-1426.
20. Puhan MA, Frey M, Büchi S, et al. The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes 2008; 6: 46.
21. Perez T, Arnould B, Grosbois J-M, et al. Validity, reliability, and responsiveness of a new short Visual Simplified Respiratory Questionnaire (VSRQ) for health-related quality of life assessment in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2009; 4: 9-18.
22. Holland A, Hill C. Physical training for interstitial lung disease. Cochrane Database Syst Rev 2008; 4: CD006322.
23. Spruit MA, Janssen DJA, Franssen FME, et al. Rehabilitation and palliative care in lung fibrosis. Respirology 2009; 14: 781-787.
24. Rammaert B, Leroy S, Cavestri B, et al. Home-based pulmonary rehabilitation in idiopathic pulmonary fibrosis. Rev Mal Respir 2011; 28: e52-e57.
25. Wallaert B, Masson N, Le Rouzic O, et al. Effects of pulmonary rehabilitation on daily life physical activity of fibrotic idiopathic interstitial pneumonia patients. ERJ Open Res 2018; 4: 00167-2017.
26. Perez-Bogerd S, Wuyts W, Barbier V, et al. Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: a randomised controlled trial. Respir Res 2018; 19: 182.
27. Wallaert B, Monge E, Le Rouzic O, et al. Physical activity in daily life of patients with fibrotic idiopathic interstitial pneumonia. Chest 2013; 144: 1652-1658.
28. Akhtar AA, Ali MA, Smith RP. Depression in patients with idiopathic pulmonary fibrosis. Chron Respir Dis 2013; 10: 127-133.
29. Ferrara G, Luppi F, Birring SS, et al. Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions. Eur Respir Rev 2018; 27: 170076.
30. Huppmann P, Sczepanski B, Boensch M, et al. Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease. Eur Respir J 2013; 42: 444-453.
31. Alison JA, McKeough ZJ. Pulmonary rehabilitation for COPD: are programs with minimal exercise equipment effective? J Thorac Dis 2014; 6: 1606-1614.
32. Holland AE, Wadell K, Spruit MA. How to adapt the pulmonary rehabilitation programme to patients with chronic respiratory disease other than COPD. Eur Respir Rev 2013; 22: 577-586.
33. Lundahl B, Burke BL. The effectiveness and applicability of motivational interviewing: a practice-friendly review of four meta-analyses. J Clin Psychol 2009; 65: 1232-1245.
34. Bourbeau J, Lavoie KL, Sedeno M. Comprehensive self-management strategies. Semin Respir Crit Care Med 2015; 36: 630-638.
35. Raghu G, Chen S-Y, Yeh W-S, et al. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11. Lancet Respir Med 2014; 2: 566-572.
36. Kreuter M, Bendstrup E, Russell A-M, et al. Palliative care in interstitial lung disease: living well. Lancet Respir Med 2017; 5: 968-980.
37. Maltais F, Bourbeau J, Shapiro S, et al. Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2008; 149: 869-878.
38. Holland AE, Mahal A, Hill CJ, et al. Home-based rehabilitation for COPD using minimal resources: a randomised, controlled equivalence trial. Thorax 2017; 72: 57-65.
39. Horton EJ, Mitchell KE, Johnson-Warrington V, et al. Comparison of a structured home-based rehabilitation programme with conventional supervised pulmonary rehabilitation: a randomised non-inferiority trial. Thorax 2018; 73: 29-36.
40. Hayton C, Clark A, Olive S, et al. Barriers to pulmonary rehabilitation: characteristics that predict patient attendance and adherence. Respir Med 2013; 107: 401-407.